Company intelligence
FutureMeds
Finding answers faster, together
About FutureMeds
FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 30 strategically located sites across 7 countries, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments. To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com LinkedIn Privacy Policy: https://www.futuremeds.com/linkedin-privacy-policy
Verified activity
Signals from FutureMeds
6 published signals
Presence & Recognition
FutureMeds @home will be exhibiting at the 2026 Rare Trials Summit in Boston.
Reported by FutureMeds
Presence & Recognition
FutureMeds will have Iwona Tongbhoyai, Gemma Whiteley, and Simon Halpin at Partnerships with Sites on Sept. 14 and DPHARM on Sept. 15-16.
Reported by FutureMeds
People
FutureMeds is recruiting for the Clinical Trials Quality Assurance program at Kozminski University, with a deadline of 15 September.
Reported by Lucas Dzioba, PhD. MRQA